Korro Bio Completes $116M Series B Financing to Expand the Frontier of Genetic Medicine Through Its Pipeline of RNA Editing Programs

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/34qHI61
via IFTTT